descriptive
Analysis v1
The FDA looked at both the good things and the possible risks of a new diabetes drug called liraglutide to decide if it's safe and helpful for patients.
Evidence from Studies
Supporting (1)
0
Community contributions welcome
0
Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
Editorial/Opinion
2010 Mar 4The study talks about how the FDA looked at both the good and bad effects of a diabetes drug called liraglutide, which is exactly what the claim says happened.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.